A biomaterial-based therapy for lower limb ischemia using Sr/Si bioactive hydrogel that inhibits skeletal muscle necrosis and enhances angiogenesis

作     者：Ye Yuan Zhaowenbin Zhang Fandi Mo Chen Yang Yiren Jiao Enci Wang Yuchong Zhang Peng Lin Chengkai Hu Weiguo Fu Jiang Chang Lixin Wang 

作者机构：Department of Vascular SurgeryZhongshan HospitalFudan University180 Fenglin RoadShanghai200032China Department of Vascular SurgeryZhongshan Xiamen HospitalFudan University668 JinhuRoadXiamen361015China Joint Centre of Translational MedicineThe First Affiliated Hospital of Wenzhou Medical UniversityWenzhou325000China Zhejiang Engineering Research Center for Tissue Repair MaterialsWenzhou InstituteUniversity of Chinese Academy of SciencesWenzhou325000China Shanghai Institute of CeramicsChinese Academy of Sciences1295 Dingxi RoadShanghai200050China 

出 版 物：《Bioactive Materials》 (生物活性材料（英文）)

年 卷 期：2023年第26卷第8期

页      面：264-278页

核心收录：

学科分类：0831[工学-生物医学工程（可授工学、理学、医学学位）] 081702[工学-化学工艺] 08[工学] 0817[工学-化学工程与技术] 0805[工学-材料科学与工程（可授工学、理学学位）] 

基　　金：supported by the National Natural Science Foundation of China(grant number:82270415) Key Project Fund of Natural Science Foundation of Fujian Science and Technology Department(grant number:2021GGB030) Shanghai Municipal Science and Technology Commission Innovation Fund(grant number:22S31904800) Fudan Zhangjiang Clinical Medicine Innovation Fund(grant number:KP7202115) Fujian Province Health Science and Technology Fund(grant number:2021GGB030) the National Natural Science Foundation of China(grant number:81970412) Medical-Industrial Cooperation Project of Zhongshan Hospital Affiliated to Fudan University(grant number:MP2021Q2C018) National Clinical Research Center for Interventional Medicine Fund(grant number:2021-004) Xiamen Municipal Health Science And Technology Program Fund(grant number:3502Z20194034) Zhongshan hospital’s Talents Supporting Plan(grant number:2019ZSGG11) Shanghai Municipal Science and Technology Commission Innovation Fund(grant number:18441902400). 

主　　题：Hindlimb ischemic diseases Strontium carbonate and calcium silicate bioceramic Bioactive hydrogel Muscle necrosis Angiogenesis 

摘      要：Muscle necrosis and angiogenesis are two major challenges in the treatment of lower-limb ischemic diseases.In this study,a triple-functional Sr/Si-containing bioceramic/alginate composite hydrogel with simultaneous bioactivity in enhancing angiogenesis,regulating inflammation,and inhibiting muscle necrosis was designed to treat lower-limb ischemic diseases.In particular,sodium alginate,calcium silicate and strontium carbonate were used to prepare injectable hydrogels,which was gelled within 10 min.More importantly,this composite hydrogel sustainedly releases bioactive Sr^(2+)and SiO_(3)^(2-) ions within 28 days.The biological activity of the bioactive ions released from the hydrogels was verified on HUVECs,SMCs,C2C12 and Raw 264.7 cells in vitro,and the therapeutic effect of the hydrogel was confirmed using C57BL/6 mouse model of femoral artery ligation in vivo.The results showed that the composite hydrogel stimulated angiogenesis,developed new collateral capillaries,and re-established the blood supply.In addition,the bioactive hydrogel directly promoted the expression of muscle-regulating factors(MyoG and MyoD)to protect skeletal muscle from necrosis,inhibited M1 polarization,and promoted M2 polarization of macrophages to reduce inflammation,thereby protecting skeletal muscle cells and indirectly promoting vascularization.Our results indicate that these bioceramic/alginate composite bioactive hydrogels are effective biomaterials for treating hindlimb ischemia and suggest that biomaterial-based approaches may have remarkable potential in treating ischemic diseases.